Labcorp Perspectives: Oncology
Labcorp Perspectives: Oncology
Podcast Description
Explore the ever-evolving world of cancer care in our insightful content series, Labcorp Perspectives as we delve into the latest advancements in oncology diagnostics and their impact on patient outcomes. Each episode brings together leading oncology experts to discuss:
• Groundbreaking research: Uncovering the cutting-edge science shaping the future of cancer treatment
• Practical applications: Learning how precision medicine translates from lab to the clinic
• Real-world challenges: Exploring the hurdles faced in oncology care and discovering potential solutions
More than just information, this series fosters collaboration and unbiased education. Labcorp Perspectives not only empowers healthcare professionals and researchers but also patients to stay informed, inspired and at the forefront of medical oncology.
Podcast Insights
Content Themes
The series covers a range of topics including groundbreaking research in cancer treatment, practical applications of precision medicine, and the real-world challenges in oncology care. For example, episodes feature discussions on tumor-agnostic therapies, the significance of genetic testing in prostate cancer care, and the clinical relevance of biomarkers, with a particular emphasis on how these advancements can directly improve patient outcomes.
Explore the ever-evolving world of cancer care in our insightful content series, Labcorp Perspectives as we delve into the latest advancements in oncology diagnostics and their impact on patient outcomes. Each episode brings together leading oncology experts to discuss:
• Groundbreaking research: Uncovering the cutting-edge science shaping the future of cancer treatment
• Practical applications: Learning how precision medicine translates from lab to the clinic
• Real-world challenges: Exploring the hurdles faced in oncology care and discovering potential solutions
More than just information, this series fosters collaboration and unbiased education. Labcorp Perspectives not only empowers healthcare professionals and researchers but also patients to stay informed, inspired and at the forefront of medical oncology.
In this insightful episode of Labcorp Perspectives Oncology, host Dr. Rebecca Previs sits down with Dr. Mark Sausen, Labcorp’s Head of Technology and Innovation, to break down a cutting-edge Phase II clinical trial exploring perioperative immunotherapy for resectable diffuse pleural mesothelioma, a rare and aggressive cancer.
Hear firsthand how the introduction of immune checkpoint blockade and an ultrasensitive tumor-informed ctDNA platform offers new hope for tracking and treating patients when imaging falls short. Dr. Sausen shares the technological breakthroughs behind molecular residual disease detection, the impact of ctDNA on progression-free survival, and practical challenges in implementing these assays across multicenter studies.
Whether you’re a clinician, researcher, or patient advocate, discover how molecular monitoring is changing the game for mesothelioma and rare cancers alike.
Tune in now to reimagine the future of oncology care.
Follow Us
- LinkedIn @labcorp
- X @labcorp
- Facebook @labcorp
- Instagram @labcorp
- YouTube @LabCorpMedia
Presented by Labcorp Oncology
www.oncology.labcorp.com
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.